Sentinus LLC’s Boston Scientific BSX Stock Holding History

Sentinus LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	5,901 +2,309	+64%	+$125K	0.02%	529
2026 Q1	$225K	Buy	+3,592	New	+$287K	0.02%	522

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sentinus LLC's BSX Position: Q2 2026 in Review

Sentinus LLC increased its Boston Scientific (BSX) stake by 64% in Q2 2026, buying an estimated $125K and bringing the position to 5,901 shares worth $252K. The position accounts for 0.02% of the portfolio, ranked #529.

Sentinus LLC first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Sentinus LLC held 5,901 shares of Boston Scientific worth $252K as of Q2 2026.
Sentinus LLC bought 2,309 Boston Scientific shares in Q2 2026, an estimated $125K.
Boston Scientific made up 0.02% of Sentinus LLC's portfolio in Q2 2026, its #529 holding.
Sentinus LLC first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.